Phreesia (NYSE:PHR) & CompuGroup Medical SE & Co. KGaA (OTCMKTS:CMPVF) Critical Review

CompuGroup Medical SE & Co. KGaA (OTCMKTS:CMPVF) and Phreesia (NYSE:PHR) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

Analyst Ratings

This is a breakdown of recent ratings and target prices for CompuGroup Medical SE & Co. KGaA and Phreesia, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CompuGroup Medical SE & Co. KGaA	0	0	0	0	0.00
Phreesia	1	9	9	0	2.42

Phreesia has a consensus price target of $16.65, suggesting a potential upside of 39.89%. Given Phreesia’s stronger consensus rating and higher probable upside, analysts plainly believe Phreesia is more favorable than CompuGroup Medical SE & Co. KGaA.

Institutional & Insider Ownership

24.3% of CompuGroup Medical SE & Co. KGaA shares are held by institutional investors. Comparatively, 92.1% of Phreesia shares are held by institutional investors. 5.2% of Phreesia shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares CompuGroup Medical SE & Co. KGaA and Phreesia’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CompuGroup Medical SE & Co. KGaA	N/A	N/A	N/A
Phreesia	1.85%	5.13%	3.12%

Valuation & Earnings

This table compares CompuGroup Medical SE & Co. KGaA and Phreesia”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CompuGroup Medical SE & Co. KGaA	N/A	N/A	N/A	C$0.56	59.70
Phreesia	$480.59 million	1.53	$2.31 million	$0.15	79.33

Phreesia has higher revenue and earnings than CompuGroup Medical SE & Co. KGaA. CompuGroup Medical SE & Co. KGaA is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Summary

Phreesia beats CompuGroup Medical SE & Co. KGaA on 10 of the 11 factors compared between the two stocks.

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical SE & Co. KGaA provides e-health services worldwide. It operates through Ambulatory Information Systems, Hospital Information Systems, Consumer and Health Management Information Systems, and Pharmacy Information Systems segments. The Ambulatory Information Systems segment develops and sells practice management software for registered physicians, medical care centers, and physician networks; offers supplementary app, internet, and intranet solutions; and delivers solutions for medical facilities, such as medica; care centers and practice associations. The Hospital Information Systems segment develop and sells of clinical and administrative solutions for inpatient sector; provides software solutions for administration, planning and provision of care in outpatient and inpatient medical facilities; and healthcare services to acute care hospitals, rehabilitation centers, welfare institutions, multi-location hospital networks, healthcare regions, regional care organizations, medical laboratories, and radiologists. The Consumer and Health Management Information Systems segment provides software interfaces for data exchange, portals for retrieving data from the German outpatient healthcare market, medical decision support tools, medication and treatment databases for healthcare service providers, solutions for the insurance industry, and digital healthcare applications, patient portals, and mobile apps; and operates telematics infrastructure business, that offers secure links, as well as security solutions for service providers. The Pharmacy Information Systems segment develop and sell administrative and billing related software applications, including procuring and shipping, managing and controlling inventory, planning, performing, and monitoring retail activities for pharmacies. The company was founded in 1987 and is headquartered in Koblenz, Germany.

About Phreesia

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.